Cable Viewer

Currently released so far... 12689 / 251,287

### Browse latest releases

2010/11 2010/12 2011/01 2011/02 2011/03 2011/04 2011/05
2010/11/28 2010/11/29 2010/11/30
2010/12/01 2010/12/02 2010/12/03 2010/12/04 2010/12/05 2010/12/06 2010/12/07 2010/12/08 2010/12/09 2010/12/10 2010/12/11 2010/12/12 2010/12/13 2010/12/14 2010/12/15 2010/12/16 2010/12/17 2010/12/18 2010/12/19 2010/12/20 2010/12/21 2010/12/22 2010/12/23 2010/12/24 2010/12/25 2010/12/26 2010/12/27 2010/12/28 2010/12/29 2010/12/30
2011/01/01 2011/01/02 2011/01/04 2011/01/05 2011/01/07 2011/01/09 2011/01/10 2011/01/11 2011/01/12 2011/01/13 2011/01/14 2011/01/15 2011/01/16 2011/01/17 2011/01/18 2011/01/19 2011/01/20 2011/01/21 2011/01/22 2011/01/23 2011/01/24 2011/01/25 2011/01/26 2011/01/27 2011/01/28 2011/01/29 2011/01/30 2011/01/31
2011/02/01 2011/02/02 2011/02/03 2011/02/04 2011/02/05 2011/02/06 2011/02/07 2011/02/08 2011/02/09 2011/02/10 2011/02/11 2011/02/12 2011/02/13 2011/02/14 2011/02/15 2011/02/16 2011/02/17 2011/02/18 2011/02/19 2011/02/20 2011/02/21 2011/02/22 2011/02/23 2011/02/24 2011/02/25 2011/02/26 2011/02/27 2011/02/28
2011/03/01 2011/03/02 2011/03/03 2011/03/04 2011/03/05 2011/03/06 2011/03/07 2011/03/08 2011/03/09 2011/03/10 2011/03/11 2011/03/13 2011/03/14 2011/03/15 2011/03/16 2011/03/17 2011/03/18 2011/03/19 2011/03/20 2011/03/21 2011/03/22 2011/03/23 2011/03/24 2011/03/25 2011/03/26 2011/03/27 2011/03/28 2011/03/29 2011/03/30 2011/03/31
2011/04/01 2011/04/02 2011/04/03 2011/04/04 2011/04/05 2011/04/06 2011/04/07 2011/04/08 2011/04/09 2011/04/10 2011/04/11 2011/04/12 2011/04/13 2011/04/14 2011/04/15 2011/04/16 2011/04/17 2011/04/18 2011/04/19 2011/04/20 2011/04/21 2011/04/22 2011/04/23 2011/04/24 2011/04/25 2011/04/26 2011/04/27 2011/04/28 2011/04/29 2011/04/30
2011/05/01 2011/05/02 2011/05/03 2011/05/04 2011/05/05 2011/05/06 2011/05/07 2011/05/08 2011/05/09 2011/05/10 2011/05/11 2011/05/12 2011/05/13 2011/05/14 2011/05/15 2011/05/16 2011/05/17 2011/05/18 2011/05/19

### Browse by creation date

66 72 73 75 79 85 86 87 88 89 90 91 92 93 94 96 97 00 01 02 03 04 05 06 07 08 09 10
1966/12
1972/02 1972/08
1973/04
1975/03
1979/08
1985/03 1985/05 1985/06
1986/05
1987/06
1988/01 1988/03 1988/07
1989/12
1990/01 1990/07 1990/08 1990/10
1991/05
1992/01 1992/03 1992/06 1992/09 1992/12
1993/01 1993/10
1994/12
1996/11
1997/06 1997/12
2000/05 2000/06 2000/09 2000/11
2001/02 2001/03 2001/06 2001/07 2001/09 2001/10 2001/11
2002/01 2002/02 2002/03 2002/04 2002/07 2002/08 2002/09 2002/11 2002/12
2003/01 2003/02 2003/03 2003/04 2003/05 2003/06 2003/07 2003/08 2003/09 2003/10 2003/11 2003/12
2004/01 2004/02 2004/03 2004/04 2004/05 2004/06 2004/07 2004/08 2004/09 2004/10 2004/11 2004/12
2005/01 2005/02 2005/03 2005/04 2005/05 2005/06 2005/07 2005/08 2005/09 2005/10 2005/11 2005/12
2006/01 2006/02 2006/03 2006/04 2006/05 2006/06 2006/07 2006/08 2006/09 2006/10 2006/11 2006/12
2007/01 2007/02 2007/03 2007/04 2007/05 2007/06 2007/07 2007/08 2007/09 2007/10 2007/11 2007/12
2008/01 2008/02 2008/03 2008/04 2008/05 2008/06 2008/07 2008/08 2008/09 2008/10 2008/11 2008/12
2009/01 2009/02 2009/03 2009/04 2009/05 2009/06 2009/07 2009/08 2009/09 2009/10 2009/11 2009/12
2010/01 2010/02

### Browse by origin

A B C D F G H I J K L M N O P Q R S T U V W Y Z
Embassy Athens Embassy Asuncion Embassy Astana Embassy Asmara Embassy Ashgabat Embassy Apia Embassy Ankara Embassy Amman Embassy Algiers Embassy Addis Ababa Embassy Accra Embassy Abuja Embassy Abu Dhabi Embassy Abidjan Consulate Auckland Consulate Amsterdam Consulate Adana American Institute Taiwan, Taipei
Embassy Bujumbura Embassy Buenos Aires Embassy Budapest Embassy Bucharest Embassy Brussels Embassy Bridgetown Embassy Bratislava Embassy Brasilia Embassy Bogota Embassy Bishkek Embassy Bern Embassy Berlin Embassy Belmopan Embassy Belgrade Embassy Beirut Embassy Beijing Embassy Banjul Embassy Bangkok Embassy Bandar Seri Begawan Embassy Bamako Embassy Baku Embassy Baghdad Consulate Barcelona
Embassy Copenhagen Embassy Conakry Embassy Colombo Embassy Chisinau Embassy Caracas Embassy Canberra Embassy Cairo Consulate Curacao Consulate Ciudad Juarez Consulate Chennai Consulate Casablanca Consulate Cape Town Consulate Calgary
Embassy Dushanbe Embassy Dublin Embassy Doha Embassy Djibouti Embassy Dili Embassy Dhaka Embassy Dar Es Salaam Embassy Damascus Embassy Dakar Consulate Dubai
Embassy Freetown Consulate Fukuoka
Embassy Guatemala Embassy Gaborone Consulate Guayaquil Consulate Guadalajara
Embassy Helsinki Embassy Harare Embassy Hanoi Consulate Ho Chi Minh City Consulate Hermosillo Consulate Hamilton Consulate Hamburg Consulate Halifax
Iran RPO Dubai Embassy Islamabad Consulate Istanbul
Embassy Jakarta Consulate Jerusalem Consulate Jeddah
Embassy Kyiv Embassy Kuwait Embassy Kuala Lumpur Embassy Kinshasa Embassy Kingston Embassy Kigali Embassy Khartoum Embassy Kathmandu Embassy Kampala Embassy Kabul Consulate Kolkata
Embassy Luxembourg Embassy Luanda Embassy London Embassy Ljubljana Embassy Lisbon Embassy Lima Embassy Lilongwe Embassy La Paz Consulate Lahore Consulate Lagos
Mission USOSCE Mission USNATO Mission UNESCO Embassy Muscat Embassy Moscow Embassy Montevideo Embassy Monrovia Embassy Minsk Embassy Mexico Embassy Mbabane Embassy Maputo Embassy Manila Embassy Manama Embassy Managua Embassy Malabo Embassy Madrid Consulate Munich Consulate Mumbai Consulate Montreal Consulate Monterrey Consulate Milan Consulate Melbourne
Embassy Nicosia Embassy Niamey Embassy New Delhi Embassy Ndjamena Embassy Nassau Embassy Nairobi Consulate Naples Consulate Naha
Embassy Ouagadougou Embassy Ottawa Embassy Oslo
Embassy Pristina Embassy Pretoria Embassy Prague Embassy Port Of Spain Embassy Port Louis Embassy Port Au Prince Embassy Phnom Penh Embassy Paris Embassy Paramaribo Embassy Panama Consulate Peshawar
Embassy Quito Consulate Quebec
REO Basrah Embassy Rome Embassy Riyadh Embassy Riga Embassy Reykjavik Embassy Rangoon Embassy Rabat Consulate Rio De Janeiro Consulate Recife
Secretary of State Embassy Suva Embassy Stockholm Embassy Sofia Embassy Skopje Embassy Singapore Embassy Seoul Embassy Sarajevo Embassy Santo Domingo Embassy Santiago Embassy Sanaa Embassy San Salvador Embassy San Jose Consulate Strasbourg Consulate St Petersburg Consulate Shenyang Consulate Shanghai Consulate Sapporo Consulate Sao Paulo
Embassy Tunis Embassy Tripoli Embassy Tokyo Embassy The Hague Embassy Tel Aviv Embassy Tehran Embassy Tegucigalpa Embassy Tbilisi Embassy Tashkent Embassy Tallinn Consulate Toronto Consulate Tijuana
USUN New York USEU Brussels US Office Almaty US Mission Geneva US Interests Section Havana US Delegation, Secretary UNVIE Embassy Ulaanbaatar
Embassy Vilnius Embassy Vienna Embassy Vatican Embassy Valletta Consulate Vladivostok Consulate Vancouver
Embassy Windhoek Embassy Wellington Embassy Warsaw
Embassy Yerevan Embassy Yaounde
Embassy Zagreb

### Browse by tag

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
AF ASEC AR AEMR AMGT AE AU AID AORC APER AS AM AFIN AMED AJ AGR ACOA ANET ASIG ABLD AL AA APECO AGAO AY AGMT APEC AINF AG ACS AECL AFFAIRS ABUD ASUP ADANA AADP AMCHAMS ARF ASEAN ADPM ATRN ALOW APCS ADCO ACAO AORG AROC AO AODE ACABQ AX AMEX AFGHANISTAN AZ AND ARM AQ ATFN AMBASSADOR ACBAQ AFSI AFSN AC AUC ASEX AER AVERY AGRICULTURE ASCH AFU AMG ATPDEA ASECKFRDCVISKIRFPHUMSMIGEG AORL ADM AN AIT
BU BR BL BO BA BB BG BM BBSR BH BEXP BK BD BTIO BT BE BY BF BX BP BRUSSELS BILAT BIDEN BC BMGT BWC BN BTIU
CH CG CF CU CE CVIS CASC CO CS CA CIDA CBW CW CMGT CI CODEL CY CPAS CJAN CD CWC CDG CIA CL CROS CAPC CTR CT CR CBSA CEUDA COM CFED CV CACS CARSON CLINTON CN CONS CM CAC CIC COPUOS CDC CONDOLEEZZA CICTE COUNTER COUNTRY CBE CKGR CHR CVR COUNTERTERRORISM CITEL CLEARANCE COE CARICOM CB CSW CITT CACM CDB CJUS CTM CAN CLMT CBC CNARC CIS
DR DA DJ DHS DAO DCM DEA DOD DOMESTIC DO DK DPRK DEPT DISENGAGEMENT DOE DTRA DS DEFENSE DE DEAX
EG EZ EUN ECON ETRD ECPS EFIN ENRG ETTC EPET EINV EAID EAIR EWWT EU EAGR EC ELAB EIND EN EMIN ESENV ENNP EFIS ELTN ET ECIN EFTA ES EINT EI ENGR ETRDEINVECINPGOVCS ENVI ETRDECONWTOCS ECINECONCS ELN ELECTIONS ENVR EXTERNAL EXIM ETRO ENIV ESA ER EK EUR EFINECONCS EUMEM EUREM EPA ERNG ENERG ECA ETRC EINVEFIN ETC EAP ECONOMY EINN ECONOMIC EXBS ECUN ENGY ECONOMICS EIAR EINDETRD ECONEFIN EURN EDU ETRDEINVTINTCS ECIP EFIM EAIDS EREL EINVETC ECONCS ETRA EAIG EUC ERD ETRN EINVECONSENVCSJA EEPET EUNCH
FR FI FJ FAS FBI FOREIGN FAO FOR FTAA FDA FM FTA FREEDOM FISO FARC FAC FINR FINANCE FOI FMLN FO
GM GG GH GR GT GAERC GA GY GCC GERARD GV GOI GZ GE GANGS GOV GTMO GL GF GAZA GLOBAL GTIP
HR HA HO HK HSTC HILLARY HU HI HURI HUMAN HYMPSK HEBRON HUMOR
IS IZ IR IC IO IN ID IGAD IT ILC IAEA ITU ICAO IMO IBRD IMF ICJ IAHRC ITF INRA INRO IWC IQ IV ICRC ICTY INRB IEFIN ILO ITRA ITALY IBET ISRAELI IL INTELSAT IRC IDP ICTR IRAQI IPR IIP INMARSAT ITPGOV ITALIAN INTERNAL IRS IA INTERPOL IEA INR IZPREL IRAJ IF ITPHUM ISRAEL IACI INDO IDA ISLAMISTS
JO JA JAMES JUS JP JOHNNIE JM JOHN JOSEPH
KSPR KNNP KWBG KAWK KISL KPAO KN KS KIPR KCRM KDEM KIRF KJUS KHLS KSCA KOMC KAWC KV KFRD KWMN KTIP KPWR KSUM KGHG KTIA KTFN KIRC KCOR KACT KMDR KGIC KOLY KUNR KIDE KMPI KPKO KCFE KVPR KRAD KPAL KFRDCVISCMGTCASCKOCIASECPHUMSMIGEG KTEX KTDB KFSC KZ KSEP KFLU KE KU KPLS KRVC KRIM KSTH KG KFLO KPOA KICC KDDG KPRV KTBT KBCT KSAF KMOC KDRG KBIO KREC KSTC KVRP KBTR KMIG KENV KNSD KCGC KWAC KFRDKIRFCVISCMGTKOCIASECPHUMSMIGEG KWMM KPRP KNEI KPAI KO KVIR KX KMCA KCRS KMFO KID KCIP KNAR KR KCRCM KBTS KSEO KHDP KFIN KOCI KGIT KNUP KPAONZ KNUC KNNPMNUC KERG KSCI KTLA KHIV KCSY KTRD KMRS KNPP KJUST KCMR KTER KRCM KCFC KSAC KCHG KREL KFTFN KCOM KLIG KDEMAF KAID KGCC KICA KHUM KSEC KPIN KESS KDEV KWWMN KOM KWNM KRFD KRGY KIFR KWMNCS KPAK KOMS KHSA
LE LY LI LO LG LH LU LA LTTE LAB LOG LT LABOR
MPOS MOPS MARR MTCR MNUC MASS MX MCAP MAR MTRE MASC MK MG MTCRE MI MD MA MO MY MU ML MRCRE MAS MEDIA MC MR MIL MW MARAD MAPP MZ MP MOPPS MTS MLS MILI MEPN MEPI MEETINGS MERCOSUR MT MCC MIK MAPS MV MILITARY MDC MEPP MASSMNUC MUCN MQADHAFI
NATO NG NL NZ NT NW NO NU NS NPT NASA NI NK NSG NE NORAD NAFTA NP NATIONAL NSSP NSF NA NGO NV NR NDP NIPP NZUS NH NC NEW NRR NAR NATOPREL NPG NSC NPA NSFO
OPDC OPRC OEXC OTRA ODIP OIIP OVIP OPIC OPCW OAS OREP OSCE OSCI OES OFDP OECD OCS OIC OPAD OVP OHUM OFFICIALS OIE OTR OMIG OSAC OBSP OFDA ON OCII
PREL PGOV PARM PINR PTER PHUM PK PREF PM PHSA PA PINS PE PBTS PCI PO PL POGOV PAK PEL PGIV PROP PP PBIO POL POLITICS POLICY PINL PBT PMIL POV PTBS PG POSTS PALESTINIAN PROV PNAT PINF PRL PAS PDOV PRAM PREO PAHO PHUMPGOV PAO PREFA PSI POLITICAL PAIGH PARMS PROG PTERE PRGOV PORG PS PGOF PKFK PSOE PEPR PPA PINT PMAR PRELP PNG PFOR PUNE PGOVLO PHUMBA PSEPC PNR POLINT PGOVE PHALANAGE PARTY PDEM PECON PGOC PY PLN PHUH PF PHUS PU PARTIES PCUL PGGV PSA PGOVSMIGKCRMKWMNPHUMCVISKFRDCA PHUMPREL
QA
RS RU RW REACTION RCMP RSO RO RP ROOD RM ROBERT RICE REGION RSP RF RIGHTS RIGHTSPOLMIL RUPREL RELATIONS RFE REPORT
SY SP SOCI SMIG SNAR SCUL SC SU SO SI SENV SZ SW SA SR SF SEVN SN STEINBERG SEN SG SYR SWE SK SH SNARCS SAARC SNARIZ SPCE SARS SNARN SCRS SYRIA SL SENVKGHG SAN ST SIPDIS SSA SPCVIS SOFA SANC SHI SHUM SIPRS
TSPA TSPL TU TBIO TRGY TPHY TS TP TW TBID TI TF TZ TD TT TN TNGD TC TX TH TL TIP THPY TV TK TERRORISM TO TRSY TURKEY TINT TFIN TAGS TR
US UNSC UNGA UK UP UNCHC UN UNMIK UNCSD UY USTR USOAS UNHRC UNFCYP UG UNAUS UNESCO UNIDROIT UNO UV UNHCR USUN UZ USNC UNCHR UNCND UNEP USEU USPS USAID UE UNVIE UAE UNDP UNODC UNCHS UNFICYP UNDESCO UNC UNPUOS UNDC UNICEF
VT VE VZ VTPREL VN VTIZ VTEG VM VAT VC VI
WFP WHO WBG WTRO WS WTO WI WB WMD WIPO WZ WWARD WHA WITH WTRQ WEU WMO WA WHTI
XA XR XL XK XV XF XM XE XTAG XS XB XU XG XT XX XW XY XZ XH XD XC XQ XI
YI YM YMCS YE
ZI ZO ZP ZR ZK ZF ZU ZL ZOELLICK ZB ZJ ZEALAND ZN ZA ZANU

### Browse by classification

CONFIDENTIAL CONFIDENTIAL//NOFORN SECRET SECRET//NOFORN UNCLASSIFIED UNCLASSIFIED//FOR OFFICIAL USE ONLY

### Community resources

Follow us on Twitter Check our Reddit Twitter this Digg this page Contact us on IRC

courage is contagious

### Viewing cable 08HELSINKI311, FINNISH GOVERNMENT APPROVES PHARMACEUTICAL

If you are new to these pages, please read an introduction on the structure of a cable as well as how to discuss them with others. See also the FAQs
Understanding cables
Every cable message consists of three parts:

- The top box shows each cables unique reference number, when and by whom it originally was sent, and what its initial classification was.
- The middle box contains the header information that is associated with the cable. It includes information about the receiver(s) as well as a general subject.
- The bottom box presents the body of the cable. The opening can contain a more specific subject, references to other cables (browse by origin to find them) or additional comment. This is followed by the main contents of the cable: a summary, a collection of specific topics and a comment section.

To understand the justification used for the classification of each cable, please use this WikiSource article as reference.
Discussing cables
If you find meaningful or important information in a cable, please link directly to its unique reference number. Linking to a specific paragraph in the body of a cable is also possible by copying the appropriate link (to be found at theparagraph symbol). Please mark messages for social networking services like Twitter with the hash tags #cablegate and a hash containing the reference ID e.g. #08HELSINKI311.

Reference ID | Created | Released | Classification | Origin
--- | --- | --- | --- | ---
08HELSINKI311 | 2008-07-09 09:35 | 2011-04-24 00:00 | UNCLASSIFIED | Embassy Helsinki

`

    VZCZCXYZ0002
    RR RUEHWEB

    DE RUEHHE #0311/01 1910935
    ZNR UUUUU ZZH
    R 090935Z JUL 08
    FM AMEMBASSY HELSINKI
    TO RUEHC/SECSTATE WASHDC 4415
    RUCPDOC/DEPT OF COMMERCE WASHDC
    INFO RUCNMEU/EU INTEREST COLLECTIVE
    RUEHNY/AMEMBASSY OSLO 4744

` `

    UNCLAS HELSINKI 000311

    SIPDIS

    E.O. 12958: N/A
    TAGS: ETRD FI PREL
    SUBJECT: FINNISH GOVERNMENT APPROVES PHARMACEUTICAL

    REFERENCE PRICING SYSTEM

    ¶1. Summary:  In a disappointing move and despite Embassy and
    industry efforts, the Finnish cabinet voted unanimously June
    25 to approve a reference pricing scheme for pharmaceuticals,
    a provision of which undermines the value of patent
    protection for medicines created and manufactured by U.S. and
    other pharmaceutical companies. Parliament is expected to
    approve the proposal at the end of the summer.  Despite the
    fact that the Ministry of Economy and Employment, the
    Ministry of Foreign Affairs and the Chancellor of Justice
    initially opposed the proposal and Prime Minister Vanhanen
    was equivocal, in the end all acquiesced and supported the
    Minister of Social Affairs and Health and the short-term
    attraction of an estimated 50 million euros annually in
    savings.  Embassy will engage key parliamentary figures in
    the next month to urge that the government develop a revised
    proposal that achieves their stated objective of containing
    health care costs but that will maintain the level of
    intellectual property protection that pharmaceutical
    companies have previously enjoyed in Finland and continue to
    enjoy elsewhere in the European Union.  If the proposal
    passes as written, post will consult with local U.S. industry
    and Washington to determine if a Special 301 listing is
    appropriate in the 2009 cycle.  End Summary.

    ----------
    Background
    ----------

    ¶2.  Product patents have been granted in Finland only since
    ¶1995.  As such, nearly all products on the Finnish market are
    still protected only by analoguous process patents.  Prior to
    2006, when Finland enacted the fix it is now proposing to
    withdraw, the level of protection for innovative medicines in
    Finland was among the lowest in the EU.  At that time,
    industry faced three major hurdles that taken together formed
    a perfect storm:  weak patent protection, liberal market
    authorization and mandatory generic substitution.

    --------------------------------------------- -------
    Finland Does the Right Thing But Then Changes Course
    --------------------------------------------- -------

    ¶3.  After much Industry and Embassy lobbying, in 2006, the
    Finnish government established criteria in Section 57(c) of
    its Medicines Act that excluded pharmaceutical products from
    generic reimbursement if they were protected by an analogus
    process patent in Finland and enjoyed valid patent protection
    in at least five other countries in the European Union.
    57(c) was the result of long negotiations and was seen by
    industry as a fair and equitable solution.  Indeed, it was
    used as an example for other countries, notably Norway, of
    the ideal legislative remedy.  Trouble started in the summer
    of 2007 when the Finnish Pharmaceutical Pricing Board (PPB)
    began cancelling the reimbursement status of some innovative
    drugs, claiming the PPB was bound only by the Health
    Insurance Act, not the the Medicines Act that contained the
    exclusion criteria. At first, Industry and Econoff believed
    this was an isolated action by an overzealous PPB chief,
    especially because when we raised it with the newly-installed
    Health Minister, she freely admitted she did not know what we
    were talking about.  Clearly she eventually got up to speed,
    because before long her ministry was overtly supporting the
    complete withdrawal of the 57(c) arrangement instead of
    supporting similar exclusion criteria for the Health
    Insurance Act as industry was proposing.

    ------------------------
    USG and Industry Efforts
    ------------------------

    ¶4. Beginning late last year, Econoff and Commercial Officer
    began working closely with the U.S. pharmaceutical company
    representatives here in Finland as well as with the local
    trade association Pharma Industry Finland (PIF) and its
    director, former Finance Minister Suvi-Anne Siimes to devise
    a strategy to head off the cancellation of 57(c).  Since
    January 2008 the Embassy has raised this at the highest level
    of Finnish government, including with the Prime Minister but
    also with virtually every other minister in the entire
    government.  Our strategy, carefully coordinated with
    industry and Washington, has focused on underscoring that
    Finland's knowledge-based economy has attracted much r&d
    investment, including health-related project funds from the
    USG.  A small IPR deficiency would undermine Finland's
    deserved reputation for innovation, a blow that was surely
    not worth the short-term gains from savings.  Industry
    reinforced this message during the visit of Alex Azar, Eli
    Lilly's Senior VP for Corporate Affairs (and a former Deputy
    Secretary of HHS) and through intensive lobbying by PIF and
    Siimes.  Siimes has also reached out to the German, French

    and Swiss Embassies whose companies also stand to suffer
    under the new arrangement.  USTR Ambassador Schwab and
    Secretary Gutierrez have written their Finnish counterparts
    on this issue and it has been raised with the Finnish Embassy
    in Washington and during the visits of high-level Finnish
    government officials.

    ----------
    Next Steps
    ----------

    ¶5.  With the cabinet's approval of the reference pricing
    scheme and the subsequent removal of the protection
    innovative products enjoyed under Section 57(c), there are
    few steps left.  Nonetheless, Embassy has a small window
    until the end of the summer when parliament will reconvene
    and consider the proposal.  Given that the MPs' party
    representatives in the cabinet have already approved the
    proposal, however, chances for success are slim.  However, we
    remain committed to raising this with parliamentary leaders
    in an attempt to encourage the development of a revised
    proposal.  If that fails, we will examine whether this
    unfortunate set of events merits Finland's inclusion on the
    Special 301 list.

    BUTLER

`